Serum concentrations and penetration into prostate of mecillinam and ampicillin

References

• Thandersenørner Andersen B., Jorgensen M., Lorenzen J. Pivmecillinam in the treatment of therapy resistant urinary tract infections: a comparison with pivmecillinam, pivampicillin and their combination. Infection 1980; 8: 271. Thandersenørner Andersen B., Jorgensen M., Lorenzen J. Pivmecillinam in the treatment of therapy resistant urinary tract infections: a comparison with pivmecillinam, pivampicillin and their combination. Infection 1980; 8: 27
   PubMed Web of Science ®Google Scholar
• Bentzen A. J., Vejlsgaard R., Jacobsen J., Tybring L. Clinical evaluation of a novel β-lactam antibiotic: pivmecillinam (FL 1039). Infection 1975; 3: 1542. Bentzen A. J., Vejlsgaard R., Jacobsen J., Tybring L. Clinical evaluation of a novel β-lactam antibiotic: pivmecillinam (FL 1039). Infection 1975; 3: 154
   PubMedGoogle Scholar
• Engberg-Pedersen H. Empirical equation for pharmacokinetic analysis of drug serum levels after oral application. Antimicrob. Agents Chemother. 1974; 6: 5543. Engberg-Pedersen H. Empirical equation for pharmacokinetic analysis of drug serum levels after oral application. Antimicrob. Agents Chemother. 1974; 6: 554
   PubMed Web of Science ®Google Scholar
• Frimodt-Møller N., Ravn T. J. Mecillinam in urinary tract infections and in septicaemia. Infection 1979; 7: 354. Frimodt-Møller N., Ravn T. J. Mecillinam in urinary tract infections and in septicaemia. Infection 1979; 7: 35
   PubMed Web of Science ®Google Scholar
• Frimodt-Møller C., Vejlsgaard R. Pivmecillinam plus pivampicillin in complicated urinary tract infection. Double-blind comparison of the combination pivmecillinam/pivampicillin and pivmecillinam alone in patients with urinary tract infection. J. Int. Med. Res. 1981; 9: 2835. Frimodt-Møller C., Vejlsgaard R. Pivmecillinam plus pivampicillin in complicated urinary tract infection. Double-blind comparison of the combination pivmecillinam/pivampicillin and pivmecillinam alone in patients with urinary tract infection. J. Int. Med. Res. 1981; 9: 283
   PubMed Web of Science ®Google Scholar
• Gippert H., Borberg A., Norberg B., Kahlmeter G., Bukh N. Symptomatic bacteriuria in non-catheterized geriatric patients with urinary incontinence: the effect of short-term treatment with pivmecillinam or the combination pivmecillinam-pivampicillin. J. Antimicrob. Chemother. 1981; 7: 1856. Gippert H., Borberg A., Norberg B., Kahlmeter G., Bukh N. Symptomatic bacteriuria in non-catheterized geriatric patients with urinary incontinence: the effect of short-term treatment with pivmecillinam or the combination pivmecillinam-pivampicillin. J. Antimicrob. Chemother. 1981; 7: 185
   PubMed Web of Science ®Google Scholar
• Grunberg E., Cleeland R., Beskid G., DeLorenzo W. In vivo synergy between 6β-amidinopenicillamic acid derivatives and other antibiotics. Antimicrob. Agents Chemother. 1976; 9: 5897. Grunberg E., Cleeland R., Beskid G., DeLorenzo W. In vivo synergy between 6β-amidinopenicillamic acid derivatives and other antibiotics. Antimicrob. Agents Chemother. 1976; 9: 589
   PubMed Web of Science ®Google Scholar
• Holmquist B. G., Almquist P. Mecillinam in prostatic fluid. Comparative study between doxycycline and mecillinam in prostatic fluid in dogs. 1984, In press8. Holmquist B. G., Almquist P. Mecillinam in prostatic fluid. Comparative study between doxycycline and mecillinam in prostatic fluid in dogs. 1984, In press
   Google Scholar
• Neu H. C. Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics. Antimicrob. Agents Chemother. 1976; 10: 5359. Neu H. C. Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics. Antimicrob. Agents Chemother. 1976; 10: 535
   PubMed Web of Science ®Google Scholar
• Pines A., Nandi A. R., Raafat H., Rahman M. Pivmecillinam and amoxycillin as combined treatment in purulent exacerbations of chronic bronchitis. J. Antimicrob. Chemother. 1977; 3(Suppl. B)14110. Pines A., Nandi A. R., Raafat H., Rahman M. Pivmecillinam and amoxycillin as combined treatment in purulent exacerbations of chronic bronchitis. J. Antimicrob. Chemother. 1977; 3(Suppl. B)141
   PubMedGoogle Scholar
• Rimmer D. Comparative trial of pivmecillinam and the combination of pivampicillin and pivmecillinam in hospitalized patients with urinary tract infection. Proc. 10th Int. Congress Chemotherapy. American Society of Microbiology, Washington, D.C 1978; 634, “Current Chemotherapy 1”11. Rimmer D. Comparative trial of pivmecillinam and the combination of pivampicillin and pivmecillinam in hospitalized patients with urinary tract infection. Proc. 10th Int. Congress Chemotherapy. American Society of Microbiology, WashingtonD.C 1978; 634, “Current Chemotherapy 1”
   Google Scholar
• Roholt K., Nielsen B., Kristensen E. Pharmacokinetic studies with mecillinam and pivmecillinam. Chemotherapy. 1975; 21: 14512. Roholt K., Nielsen B., Kristensen E. Pharmacokinetic studies with mecillinam and pivmecillinam. Chemotherapy. 1975; 21: 145
   Google Scholar
• Roholt K., Nielsen B., Kristensen E. Clinical pharmacology of pivampicillin. Antimicrob. Agents Chemother. 1974; 6: 56313. Roholt K., Nielsen B., Kristensen E. Clinical pharmacology of pivampicillin. Antimicrob. Agents Chemother. 1974; 6: 563
   PubMed Web of Science ®Google Scholar